L. Daniel Browne, CEO and President at Revance Therapeutics, Inc. (RVNC), sold 54,566 shares at $31.43 ($1.7M) on 2018-03-07, disclosed to the SEC on 2018-03-09.
Open-market sale of $1.7M RVNC by CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.43 | 27,283 | $858K | 50.0% |
| 2 | $31.43 | 27,283 | $858K | 50.0% |
| Total | $31.43 avg | 54,566 | $1.7M | 100% |
| Filing → |
| RVNC | SELL | 2018-03-16 | $376K | — | Filing → |
| RVNC | SELL | 2017-11-24 | $190K | — | Filing → |
| RVNC | SELL | 2017-10-20 | $401K | — | Filing → |